News
The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.
Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...
2h
Verywell Health on MSNThe Best Time to Get an RSV Vaccine for Older AdultsThe CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...
Teams can scale Qwen3’s capabilities to single-node GPU instances or local development machines, avoiding the need for massive GPU clusters.
10h
GlobalData on MSNMixed results from Roche’s mAb in COPDRoche’s IgG2 monoclonal antibody (mAb) astegolimab has yielded mixed results in chronic obstructive pulmonary disease (COPD), ...
The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine ...
2h
ABC7 KABC on MSNUber files federal lawsuit against well-known LA personal injury attorneys, accuses them of fraudUber claims the L.A. law firms sent people involved in accidents with Uber drivers to certain medical groups for unnecessary ...
The project, launched in June 2024 and set for full operation in mid-2026, has received strong backing from local authorities ...
In May, biotech iTeos Therapeutics decided to close down after being abandoned by GSK over the disappointing mid-stage performance of its anti-TIGIT antibody belrestotug.
Like going to the supermarket and staring at aisles of cereal and sauces, the average ChatGPT user is currently faced with an ...
StockStory.org on MSN3h
Why Azenta (AZTA) Stock Is Up TodayShares of life sciences company Azenta (NASDAQ:AZTA) jumped 5.7% in the afternoon session after the investment firm Stephens ...
"Uber’s accusations rely on rhetoric, not reality," Downtown LA Law Group claimed. "The company never tried a single case it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results